Efficacy and Safety of Olokizumab With Rheumatoid Arthritis With Previously Failed to Anti-tumor Necrosis Factor (Anti-TNF) Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01463059
Recruitment Status : Completed
First Posted : November 1, 2011
Last Update Posted : March 25, 2013
Information provided by (Responsible Party):
UCB Pharma ( UCB Japan Co. Ltd. )

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : February 2013
  Study Completion Date : February 2013
  Certification/Extension First Submitted : March 19, 2013